Where does SenoRx, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), SenoRx, Inc. ranks #6,838 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does SenoRx, Inc. hold?

SenoRx, Inc. holds 49 US utility patents granted between 2015 and 2023, spanning 11 technology areas.

What is SenoRx, Inc.'s Innovation Score?

SenoRx, Inc. has an Innovation Score of 35.5 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does SenoRx, Inc. focus on?

SenoRx, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 46 patents, ranking #412 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is SenoRx, Inc.'s patent grant rate increasing or decreasing?

SenoRx, Inc.'s recent grant velocity is -74% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for SenoRx, Inc.'s patents?

SenoRx, Inc.'s patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the SenoRx, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

SenoRx, Inc.

USPTO PatentsView assignee record - 49 granted patents across 11 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Senorx ranks #6,838 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 11 technology areas.

#6,838
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.5/100): 13.1
avg claims per patent: -74%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6838 · US Corporation #6,838 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 49 grants
UPPER-Q #6,838/49,997
PHOTO-FINISH Safariland
CPC-FOCUS A61B · 11 areas
INNOV-THIN 35.5/100
CLAIMS-RICH 13.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -74% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Safariland, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Senorx’s 35.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.5 pts (38%) Velocity 2.4 pts (7%) Breadth 11.7 pts (33%) Claim depth 7.9 pts (22%)

Qualcomm Incorporated · highest

85
Beet · near

36
Brasscraft Manufactu… · near

36
Fu Da Tong Technology · near

36
Natura COSMÉTICOS · near

36
SenoRx · this assignee

36
3D Lighting… · lowest

7

What this shows Senorx's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Senorx?

Each dot is one of Senorx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Senorx’s own 13.1 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Senorx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Senorx's grants concentrate

SenoRx, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 93.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (9 grants) versus a trough of 1 in 2021. By volume, Senorx sits between Switch, Ltd. and Spigen, Inc..

Senorx's three-year grant acceleration

SenoRx, Inc. shows 5 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Switch

49
Safariland

49
Safran Landing Sy…

49
Samsung Dispiay

49
Sigray

49
Skylo

49
Somalogic

49
Spigen

49
Senorx ◀

49

What this shows SenoRx holds 49 patents at rank #6,842, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near SenoRx

By rank, the assignees closest to #6,842 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in SenoRx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for SenoRx, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), SenoRx ranks #412 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Brasscraft Manufacturing Company 36 Fu Da Tong Technology Co., Ltd. 36 Natura COSMÉTICOS S.A. 36 Beet, Inc. 36

Senorx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

SenoRx, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	18.4%
2016	8	16.3%
2017	8	16.3%
2018	5	10.2%
2019	9	18.4%
2020	4	8.2%
2021	1	2.0%
2022	3	6.1%
2023	2	4.1%

Which technologies does SenoRx, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 46

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

B23Q - Details, Components, OR Accessories FOR Machine Tools, e.g. Arrangements FOR Copying OR Controlling ; Machine Tools IN General Characterised BY THE Construction OF Particular Details OR COMPONENTS; Combinations OR Associations OF Metal-working Machines, NOT Directed TO A Particular Result 7

F21V - Functional Features OR Details OF Lighting Devices OR Systems THEREOF; Structural Combinations OF Lighting Devices With Other Articles, NOT Otherwise Provided FOR 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

B01D - Separation 2

G06T - Image Data Processing OR Generation, IN General 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

SenoRx, Inc.'s patent record in context - here's where to go next.

SenoRx, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 93.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #6,838 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare SenoRx, Inc. against Switch, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.